Umoja Biopharma

CEO - Andrew Scharenberg
CEO - Andrew Scharenberg
USA | Funding: $363M (+)

Website: https://umoja-biopharma.com

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.